Voloridge Investment Management
NVAX icon

Voloridge Investment Management’s Novavax NVAX Stock Holding History

Voloridge Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-367,552
Closed -$4.64M – 1311
2024
Q3 		$4.64M Sell
367,552
-1,738,508
-83% -$22.4M 0.02% 796
2024
Q2 		$26.7M Buy
+2,106,060
New +$21.2M 0.1% 285
2023
Q2 		– Sell
-957,974
Closed -$6.64M – 1495
2023
Q1 		$6.64M Buy
957,974
+205,487
+27% +$1.89M 0.03% 582
2022
Q4 		$7.74M Sell
752,487
-581,219
-44% -$10.3M 0.04% 513
2022
Q3 		$24.3M Buy
1,333,706
+485,567
+57% +$21M 0.13% 224
2022
Q2 		$43.6M Buy
848,139
+432,661
+104% +$22.4M 0.23% 127
2022
Q1 		$30.6M Buy
+415,478
New +$37M 0.17% 161
2015
Q4 		– Sell
-37,827
Closed -$5.35M – 268
2015
Q3 		$5.35M Buy
37,827
+24,703
+188% +$5.54M 0.25% 103
2015
Q2 		$2.92M Buy
+13,124
New +$2.31M 0.15% 148

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Voloridge Investment Management's NVAX Position: Q4 2024 in Review

Voloridge Investment Management sold out of Novavax (NVAX) in Q4 2024, closing a stake of 367,552 shares — an estimated $4.64M sold.

Voloridge Investment Management first reported a position in NVAX in Q2 2015 and held it in 9 quarters. The position peaked at $43.6M in Q2 2022. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2024.

  • Voloridge Investment Management reported no remaining Novavax position as of Q4 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 367,552 Novavax shares in Q4 2024, an estimated $4.64M.
  • Voloridge Investment Management first reported a position in Novavax in Q2 2015 and held it in 9 quarters.
  • Voloridge Investment Management's Novavax position peaked at $43.6M in Q2 2022.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2024.

Based on Voloridge Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.